ASX - By Stock
|
MSB |
Re:
2022 MSB - The Year of Downfall
|
|
CytokineRelease
|
28 |
7.7K |
5 |
26/03/22 |
26/03/22 |
ASX - By Stock
|
28
|
7.7K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2022 MSB - The Year of Downfall
|
|
CytokineRelease
|
28 |
7.7K |
3 |
26/03/22 |
26/03/22 |
ASX - By Stock
|
28
|
7.7K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2022 MSB - The Year of Downfall
|
|
CytokineRelease
|
28 |
7.7K |
3 |
26/03/22 |
26/03/22 |
ASX - By Stock
|
28
|
7.7K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2022 MSB - The Year of Downfall
|
|
CytokineRelease
|
28 |
7.7K |
4 |
26/03/22 |
26/03/22 |
ASX - By Stock
|
28
|
7.7K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
2022 MSB - The Year of Downfall
|
|
CytokineRelease
|
28 |
7.7K |
0 |
26/03/22 |
26/03/22 |
ASX - By Stock
|
28
|
7.7K
|
0
|
|
ASX - By Stock
|
MSB |
2022 MSB - The Year of Downfall
|
|
CytokineRelease
|
28 |
7.7K |
5 |
26/03/22 |
26/03/22 |
ASX - By Stock
|
28
|
7.7K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
CytokineRelease
|
4.7K |
1.1M |
2 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
2
|
|
ASX - By Stock
|
WHC |
Re:
Target $4.61
|
|
CytokineRelease
|
6.8K |
2.2M |
3 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
6.8K
|
2.2M
|
3
|
|
ASX - By Stock
|
WHC |
Re:
Target $4.61
|
|
CytokineRelease
|
6.8K |
2.2M |
6 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
6.8K
|
2.2M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
looks like a leak from the FDA
|
|
CytokineRelease
|
13 |
7.4K |
1 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
13
|
7.4K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
CytokineRelease
|
18K |
6.9M |
2 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
18K
|
6.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Class Action
|
|
CytokineRelease
|
218 |
69K |
2 |
06/03/22 |
06/03/22 |
ASX - By Stock
|
218
|
69K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: S&P DJI Announces March 2022 Quarterly Rebalance
|
|
CytokineRelease
|
96 |
31K |
1 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
96
|
31K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: S&P DJI Announces March 2022 Quarterly Rebalance
|
|
CytokineRelease
|
96 |
31K |
2 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
96
|
31K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: S&P DJI Announces March 2022 Quarterly Rebalance
|
|
CytokineRelease
|
96 |
31K |
3 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
96
|
31K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
CytokineRelease
|
1.5K |
510K |
2 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
1.5K
|
510K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
CytokineRelease
|
1.5K |
510K |
0 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
1.5K
|
510K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
CytokineRelease
|
1.0K |
334K |
2 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
1.0K
|
334K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Novartis countdown
|
|
CytokineRelease
|
373 |
113K |
1 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
373
|
113K
|
1
|
|
ASX - By Stock
|
WHC |
Re:
Target $4.61
|
|
CytokineRelease
|
6.8K |
2.2M |
0 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
6.8K
|
2.2M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
CytokineRelease
|
1.0K |
334K |
2 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
1.0K
|
334K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
CytokineRelease
|
1.0K |
334K |
0 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
1.0K
|
334K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
I believe that Stem Cells are the future
|
|
CytokineRelease
|
2 |
468 |
1 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
2
|
468
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Where is Dr McFluffin?
|
|
CytokineRelease
|
3 |
803 |
2 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
3
|
803
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Appoints Dr Eric Rose as Chief Medical Officer
|
|
CytokineRelease
|
147 |
42K |
0 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
147
|
42K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Appoints Dr Eric Rose as Chief Medical Officer
|
|
CytokineRelease
|
147 |
42K |
0 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
147
|
42K
|
0
|
|
ASX - By Stock
|
NXL |
Re:
Macquarie’s Bastard Child
|
|
CytokineRelease
|
65 |
32K |
2 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
65
|
32K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
WHo is ready for 85% surge
|
|
CytokineRelease
|
7 |
2.8K |
3 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
7
|
2.8K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
CytokineRelease
|
1.5K |
510K |
2 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
1.5K
|
510K
|
2
|
|
ASX - By Stock
|
NXL |
Re:
Macquarie’s Bastard Child
|
|
CytokineRelease
|
65 |
32K |
3 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
65
|
32K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
CHF - MSB's Dark Horse with Multi-billion dollar potential
|
|
CytokineRelease
|
516 |
158K |
5 |
30/01/22 |
30/01/22 |
ASX - By Stock
|
516
|
158K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer Covid Pill: Gameover for MSB's treatment
|
|
CytokineRelease
|
41 |
10K |
2 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
41
|
10K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Walking dead invade MSB offices
|
|
CytokineRelease
|
35 |
8.3K |
0 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
35
|
8.3K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Walking dead invade MSB offices
|
|
CytokineRelease
|
35 |
8.3K |
1 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
35
|
8.3K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Reality
|
|
CytokineRelease
|
317 |
75K |
0 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
317
|
75K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Reality
|
|
CytokineRelease
|
317 |
75K |
3 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
317
|
75K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
CytokineRelease
|
2.8K |
1.2M |
7 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Reality
|
|
CytokineRelease
|
317 |
75K |
1 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
317
|
75K
|
1
|
|
ASX - By Stock
|
CPN |
Re:
Ann: Yarabrook Drilling Intersects Nickel and Copper Sulphides
|
|
CytokineRelease
|
178 |
69K |
4 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
178
|
69K
|
4
|
|
ASX - By Stock
|
NXL |
Re:
not selling
|
|
CytokineRelease
|
344 |
94K |
1 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
344
|
94K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
RWE for 2nd MSB COVID-19 ARDS P3 Trial
|
|
CytokineRelease
|
905 |
293K |
4 |
15/01/22 |
15/01/22 |
ASX - By Stock
|
905
|
293K
|
4
|
|
ASX - By Stock
|
WHC |
Re:
Target $4.61
|
|
CytokineRelease
|
6.8K |
2.2M |
9 |
15/01/22 |
15/01/22 |
ASX - By Stock
|
6.8K
|
2.2M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Has the market lost trust in MSB?
|
|
CytokineRelease
|
245 |
52K |
5 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
245
|
52K
|
5
|
|
ASX - By Stock
|
NXL |
Re:
not selling
|
|
CytokineRelease
|
344 |
94K |
3 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
344
|
94K
|
3
|
|
ASX - By Stock
|
NXL |
Re:
not selling
|
|
CytokineRelease
|
344 |
94K |
2 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
344
|
94K
|
2
|
|
ASX - By Stock
|
NXL |
Re:
not selling
|
|
CytokineRelease
|
344 |
94K |
2 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
344
|
94K
|
2
|
|
ASX - By Stock
|
LYC |
Re:
The faster the rise...
|
|
CytokineRelease
|
399 |
158K |
14 |
09/01/22 |
09/01/22 |
ASX - By Stock
|
399
|
158K
|
14
|
|
ASX - By Stock
|
LYC |
Re:
The faster the rise...
|
|
CytokineRelease
|
399 |
158K |
8 |
09/01/22 |
09/01/22 |
ASX - By Stock
|
399
|
158K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
CytokineRelease
|
880 |
217K |
4 |
08/01/22 |
08/01/22 |
ASX - By Stock
|
880
|
217K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
CytokineRelease
|
880 |
217K |
2 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
880
|
217K
|
2
|
|